LENSAR, INC.

lensar-inc-logo

LENSAR, Inc., the global leader in next generation femtosecond laser technology for refractive cataract surgery, continues to focus on astigmatism and support the pursuit of best possible results for patients with its Streamline® IV system upgrade. Unique to the LENSAR Laser System, Streamline IV includes various enhancements that offer cataract surgeons advanced adaptation and customization for treatment planning and other essential steps of the cataract surgery procedure with the highest leve... ls of precision, accuracy, and efficiency. To help surgeons confidently manage astigmatism and optimize refractive outcomes for both toric IOLs and arcuate incisions, the LENSAR Laser with Streamline IV has incorporated extreme treatment planning insights. This includes quick and easy patient docking, as well as superior imaging capabilities with LENSAR’s proprietary Augmented Reality™ 3-D model. This technology facilitates enhanced procedure outcomes by adapting individualized treatment plans including precise laser delivery and efficient lens fragmentation that can reduce, and potentially eliminate, the amount of ultrasonic energy delivered into the eye. Additionally, the IntelliAxis Refractive Capsulorhexis® feature provides another dimension of accuracy with biomechanically stable, steep axis markings that help guide precise toric IOL alignment. The marks remain visible postoperatively to help identify any rotation and guide realignment of the toric IOL to its optimal position. IntelliAxis Refractive Capsulorhexis also incorporates wireless transfer of preoperative diagnostics from the Cassini® Corneal Shape Analyzer and Pentacam® to help eliminate transcription errors, save time, and guide more confident astigmatism correction. Iris registration further contributes to the system’s accuracy by comparing a pre-op image taken while the eye is docked and adaptively compensates for cyclorotation for confidence incision placement. LENSAR has recently expanded the platform’s capabilities to include the creation of micro radial incisions that allow surgeons to treat additional corneal conditions post-cataract surgery and support presbyopia inlay procedures. Building on the strength of LENSAR’s foundational femtosecond cataract laser platform, the LENSAR Laser with Streamline IV simplifies practice and surgical workflows while also revolutionizing a surgeon’s ability to deliver optimal outcomes for astigmatic patients.

#SimilarOrganizations #People #Financial #Website #More

LENSAR, INC.

Social Links:

Industry:
Health Care Hospital Medical Device

Founded:
2004-01-01

Address:
Orlando, Florida, United States

Country:
United States

Website Url:
http://www.lensar.com

Total Employee:
101+

Status:
Active

Contact:
888-536-7271

Email Addresses:
[email protected]

Total Funding:
177.52 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

channel-medsystems-logo

Channel Medsystems

Channel Medystems is a clinical-stage medical technology engaged in the development of proprietary cryo-ablation delivery technologies.

sesen-bio-inc-logo

Sesen Bio, Inc.

Sesen Bio, Inc. is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.

injectsense-logo

Injectsense

Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.

jefferson-health-system-logo

Jefferson Health System

Jefferson Health System is a health care company that offers an extended care community for personal health.

p3-health-partners-logo

P3 Health Partners

P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.

seno-medical-instruments-logo

Seno Medical Instruments

Seno Medical is commercialization efforts in opto-acoustic imaging of breast cancer.

somalogic-logo

SomaLogic

SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.

xenex-logo

Xenex

Xenex offers Pulsed Xenon Full Spectrum, a UV disinfection solution that reduces the bacterial load associated with the risk for HAIs.


Current Advisors List

not_available_image

Ramón Naranjo Tackman Advisor @ LENSAR, Inc.
Advisor

not_available_image

Stephen Klyce Advisor @ LENSAR, Inc.
Advisor

harvey-uy_image

Harvey Uy Advisor @ LENSAR, Inc.
Advisor

josh-bilenker_image

Josh Bilenker Board of Directors @ LENSAR, Inc.
Board_member
2008-01-01

steven-a-elms_image

Steven A. Elms Chairman @ LENSAR, Inc.
Board_member

louis-nichamin_image

Louis Nichamin Medical Advisory Board @ LENSAR, Inc.
Advisor

adrian-glasser_image

Adrian Glasser Advisor @ LENSAR, Inc.
Advisor

rbruce-wallace_image

R.Bruce Wallace Medical Advisory Board @ LENSAR, Inc.
Advisor

Current Employees Featured

ronald-krueger_image

Ronald Krueger
Ronald Krueger Co-Founder @ LENSAR, Inc.
Co-Founder

mark-packer_image

Mark Packer
Mark Packer Medical Monitor @ LENSAR, Inc.
Medical Monitor
2010-01-01

darcy-wendel_image

Darcy Wendel
Darcy Wendel Vice President of Clinical Affairs @ LENSAR, Inc.
Vice President of Clinical Affairs
2022-01-01

nicholas-curtis_image

Nicholas Curtis
Nicholas Curtis CEO @ LENSAR, Inc.
CEO
2012-03-01

lothar-koob_image

Lothar Koob
Lothar Koob COO @ LENSAR, Inc.
COO

Founder


not_available_image

Randy Frey

ronald-krueger_image

Ronald Krueger

Stock Details


Company's stock symbol is NASDAQ:LNSR

Acquisitions List

Date Company Article Price
2018-01-11 Precision Eye Services Precision Eye Services acquired by LENSAR, Inc. N/A

Investors List

aisling-capital_image

Aisling Capital

Aisling Capital investment in Private Equity Round - LENSAR, Inc.

aisling-capital_image

Aisling Capital

Aisling Capital investment in Debt Financing - LENSAR, Inc.

florida-opportunity-fund_image

Florida Opportunity Fund

Florida Opportunity Fund investment in Debt Financing - LENSAR, Inc.

pdl-biopharma_image

PDL Biopharma

PDL Biopharma investment in Venture Round - LENSAR, Inc.

florida-growth-fund_image

Florida Growth Fund

Florida Growth Fund investment in Venture Round - LENSAR, Inc.

aisling-capital_image

Aisling Capital

Aisling Capital investment in Venture Round - LENSAR, Inc.

pdl-biopharma_image

PDL Biopharma

PDL Biopharma investment in Debt Financing - LENSAR, Inc.

florida-opportunity-fund_image

Florida Opportunity Fund

Florida Opportunity Fund investment in Series A - LENSAR, Inc.

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Debt Financing - LENSAR, Inc.

florida-growth-fund_image

Florida Growth Fund

Florida Growth Fund investment in Venture Round - LENSAR, Inc.

Official Site Inspections

http://www.lensar.com Semrush global rank: 4.52 M Semrush visits lastest month: 2.35 K

  • Host name: 76.34.109.208.host.secureserver.net
  • IP address: 208.109.34.76
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "LENSAR, Inc." on Search Engine